The dry powder compound BonuTab® contains fillers, binders, disintegrant, lubricants and – if required – pigments for coloring issues. According to customer needs and depending on active pharmaceutical ingredients (API) the components of the premix can be individually adapted. An optimization of the tablet formulation can be done. Preparation of the complete tablet mass in just one step by blending BonuTab® with the API.

Functions: Coating System

Certifications & Compliance: EXCiPACT, European Pharmacopeia (Ph. Eur.), ISO 9001, United States Pharmacopeia (USP)

Dosage Form: Capsules, Tablets

  • TypeDocument Name
View All Documents

Knowde Enhanced TDS

Identification & Functionality

Pharma & Nutraceuticals Functions

Features & Benefits

Product Information
  • By using a typical physical mixture of single components, challenges like weighing each component, bad flowability and stickiness of the tablet mass are critical steps before and during the production process. The risk of deviations in the tablet weight or hardness can occur after the compression. Additional criteria that should be considered, if a traditional blend is used in-house, are costs for purchase, quality control and storage of each single excipient.
  • BonuTab® decreases these criteria to a minimum and reduces set-up and analysis costs by using only one instead of several excipients. Also, switching from wet granulation to direct compression with BonuTab® saves production costs and can be easily realized. The premixed tablet powder gives the formulation more robustness and complies with all technical standards for a tablet.

Applications & Uses

Dosage Form

Properties

Physical Form

Regulatory & Compliance

Regulatory and Quality Aspects

All BonuTab® formulations are developed to comply with official regulatory requirements of the user’s country for pharmaceutical products and for nutritional or dietary supplements.

Technical Details & Test Data

Product Performance

BonuTab® - Product Performance